O-3 Efficacy and safety of entrectinib in NTRK fusion-positive gastrointestinal cancers: Updated integrated analysis of three clinical trials (STARTRK-2, STARTRK-1 and ALKA-372-001)Manish R. Patel,Salvatore Siena,George D. Demetri,Robert C. Doebele,Younbyoung Chae, P. Conkling,Ignacio Garrido-Laguna, Flavia Longo,Christian Rolfo,Darren Sigal,A. Drilon,Stephen V. Liu,Koichi Goto,Lyudmilla Bazhenova, S. Lonardi,Fortunato Ciardiello, Xinhui Huang,S. Osborne,A. Aziez,F. de BraudANNALS OF ONCOLOGY（2020）引用 15|浏览65暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
